Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model.
Moustafa M, Dähling KK, Günther A, Riebandt L, Smit DJ, Riecken K, Schröder C, Zhuang R, Krech T, Kriegs M, Fehse B, Izbicki JR, Fischer L, Nashan B, Li J, Jücker M.
Moustafa M, et al. Among authors: li j.
Cancers (Basel). 2022 Apr 8;14(8):1882. doi: 10.3390/cancers14081882.
Cancers (Basel). 2022.
PMID: 35454789
Free PMC article.